Lo Steven 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Jul 24, 2019
Insider Transaction Report
Form 4
Lo Steven
Chief Commercial Officer
Transactions
- Sale
COMMON STOCK
2019-07-22$10.04/sh−1,852$18,600→ 19,557 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 22, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.04 to $10.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.